期刊文献+

“单抗”药物研发进展及在芜湖市实现其产业化的探讨

Investigation of Industrialization of Monoclonal Antibody Drugs in the City of Wuhu
下载PDF
导出
摘要 单克隆抗体药物具特异性强、见效快、副作用低等优点,成为医药行业增速最快的领域之一,在疾病治疗方面展现出广阔的应用前景,创造了巨大的经济和社会效益。本文介绍了"单抗"药物的研发进展,分析了我国相关产业发展中普遍存在的问题,并结合芜湖市相关产业发展、政策等情况对芜湖"单抗"药物产业化提出了一些看法与建议。 Monoclonal antibody drugs have advantages of high specificity, rapid curative effect and low sideeffect. With broad application prospects in the treatment of disease, it creates enormous economic and social benefits, and becomes one of the fastest growing areas of the pharmaceutical industry. This paper described the development progress of research and industrialization of it, analyzed the common problems, and presented some views and suggestions on the industrialization of Monoclonal antibody drugs in the city of Wuhu.
出处 《海峡药学》 2016年第8期278-281,共4页 Strait Pharmaceutical Journal
关键词 单抗克隆抗体药物 研发 产业化 分析 Monoclonal antibody drugs Research Industrialization Analysis
  • 相关文献

参考文献14

二级参考文献82

共引文献175

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部